References
- Heng Y, He M, Congdon N. The worldwide epidemic of diabetic retinopathy. Indian J Ophthalmol. 2012;60(5):428–431.
- El-Agamy A, Alsubaie S. Corneal endothelium and central corneal thickness changes in type 2 diabetes mellitus. Clin Ophthalmol. 2017;11:481–486.
- Mansour SE, Browning DJ, Wong K, et al. The evolving treatment of diabetic retinopathy. Clin Ophthalmol. 2020; 14:653–678.
- Ogurtsova K, Fernandes J, Huang Y, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017; 128:40–50.
- Ajlan R, Silva P, Sun J. Vascular endothelial growth factor and diabetic retinal disease. Semin Ophthalmol. 2016;31(1-2):40–48.
- Novotny HR, Alvis DL. A method of photographing fluorescence in circulating blood in the human retina. Circulation. 1961; 24:82–86.
- Matsuo T, Yamaoka A. Retinal vasculitis revealed by fluorescein angiography in patients with inflammatory bowel disease. Jpn J Ophthalmol. 1998;42(5):398–400.
- Abraham A, Saboo US, Ducca BL, et al. The detection of occult retinal vasculitis on fluorescein angiography in pediatric uveitis. Ophthalmol Retina. 2020;4(2):198–203.
- Saari KM. Anterior segment fluorescein angiography in inflammatory diseases of the cornea. Acta Ophthalmol (Copenh). 1979;57(5):781–793.
- Zett C, Stina D, Kato R, et al. Comparison of anterior segment optical coherence tomography angiography and fluorescein angiography for iris vasculature analysis. Graefes Arch Clin Exp Ophthalmol. 2018;256(4):683–691.
- Azad R, Chandra P, Khan MA, et al. Role of intravenous fluorescein angiography in early detection and regression of retinopathy of prematurity. J Pediatr Ophthalmol Strabismus. 2008;45(1):36–39.
- Xu K, Tzankova V, Li C, et al. Intravenous fluorescein angiography-associated adverse reactions. Can J Ophthalmol. 2016;51(5):321–325.
- Stoken DJ, Hoffman ME. Anterior uveitis following fluorescein angiography. Trans Pa Acad Ophthalmol Otolaryngol. 1986;38(1):294–295.
- Antoszyk AN, de Juan E, Landers M. Subretinal hemorrhage during fluorescein angiography. Am J Ophthalmol. 1987;103(1):111–112.
- Bandello F, Brancato R, Lattanzio R, et al. Biomicroscopy versus fluorescein angiography of the iris in the detection of diabetic iridopathy. Graefes Arch Clin Exp Ophthalmol. 1993;231(8):444–448.
- Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early treatment diabetic retinopathy study research group. Ophthalmology. 1991;98:766–785.
- Brancato R, Trabucchi G. Fluorescein and indocyanine green angiography in vascular chorioretinal diseases. Semin Ophthalmol. 1998;13(4):189–198.
- Brancato R, Bandello F, Lattanzio R. Iris fluorescein angiography in clinical practice. Surv Ophthalmol. 1997;42(1):41–70.
- Papadakou P, Chatziralli I, Papathanassiou M, et al. The effect of diabetes mellitus on corneal endothelial cells and central corneal thickness: a case-control study. Ophthalmic Res. 2020;63(6):550–554.
- McCarey BE, Edelhauser HF, Lynn MJ. Review of corneal endothelial specular microscopy for FDA clinical trials of refractive procedures, surgical devices, and new intraocular drugs and solutions. Cornea. 2008;27(1):1–16.
- Weston BC, Bourne WM, Polse KA, et al. Corneal hydration control in diabetes mellitus. Invest Ophthalmol Vis Sci. 1995;36(3):586–595.
- Zakov ZN, Lewis ML. Iris fluorescein angiography in diabetic vitrectomy patients. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1978;206(1):17–24.
- Bandello F, Brancato R, Lattanzio R, et al. Relation between iridopathy and retinopathy in diabetes. Br J Ophthalmol. 1994;78(7):542–545.
- Laatikainen L. The fluorescein angiography revolution: a breakthrough with sustained impact. Acta Ophthalmol Scand. 2004;82(4):381–392.
- Colak S, Kazancı B, Soba D, et al. Effects of diabetes duration and HgA1C level on corneal endothelial morphology. Eur J Ophthalmol. 2021;31(3):967–975.
- Cankurtaran V, Tekin K. Cumulative effects of smoking and diabetes mellitus on cornea endothelial cell parameters. Cornea. 2018; 01:1–6.
- Chowdhury B, Bhadra S, Mittal P, et al. Corneal endothelial morphology and Central corneal thickness in type 2 diabetes mellitus patients. Indian J Ophthalmol. 2021;69(7):1718–1724.
- Chatziralli I, Papadakou P, Dimitriou E, et al. The effect of intravitreal anti-vascular endothelial growth factor injections on corneal endothelium in patients with diabetic macular edema. Cutan Ocul Toxicol. 2021;40(2):66–69.
- Calli U, Ozturk Y, Demir G. The effect of fluoroscein on corneal endothelial structure and morphology in diabetic retinopathy patients undergone fundus fluorescein angiography. Beyoglu Eye J. 2022;7(1):35–38.
- Shiraya K, Nagataki S. Movement of fluorescein monoglucuronide in the rabbit cornea. Diffusion in the stroma and endothelial permeability. Invest Ophthalmol Vis Sci. 1986;27(1):24–28.
- Schalnus R, Ohrloff C. Permeability of the limiting cell layers of the cornea in vivo. Lens Eye Toxic Res. 1990;7(3-4):371–384.
- Srinivas SP, Goyal A, Talele DP, et al. Corneal epithelial permeability to fluorescein in humans by a multi-drop method. PLoS One. 2018;13(6):e0198831.